PTPRC and neoplasm: Foxp3+ T regulatory cells (Tregs), B220+CD3 B cells, MHC-IICD64+ myeloid cells (putative monocyte-derived tumor-associated macrophages [TAMs]), CD11cSIRPa+MHC-II+ myeloid cells (putative activated macrophages [aMacs]), CD11c+MHC-II+ DCs, and MHC-II+ SIRPaDIM myeloid cells (Figure S2A) (DeNardo and Ruffell, 2019; Jahchan et al., 2019; Veillette and Chen, 2018).